Bevacizumab reported to increase overall survival in advanced cervical cancer

被引：0
|
作者：
Lake, Francesca
机构：
来源：
FUTURE ONCOLOGY | 2014年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：787 / 787
页数：1
相关论文
共 50 条
  • [21] Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer
    Thomas Papathemelis
    Stella Knobloch
    Michael Gerken
    Anton Scharl
    Michael Anapolski
    Atanas Ignatov
    Elisabeth C. Inwald
    Olaf Ortmann
    Sophia Scharl
    Monika Klinkhammer-Schalke
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 1369 - 1376
  • [22] Predictors of Interstitial Brachytherapy Utilization in Locally Advanced Cervical Cancer and Impact on Overall Survival
    Elbanna, M.
    Agrawal, N.
    Holmes, J. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E253 - E254
  • [23] Absolute band neutrophils count is a predictor of overall survival in advanced uterine cervical cancer
    Rosekeila Simões Nomelini
    Sâmela Daiere Soares Mota
    Eddie Fernando Candido Murta
    Archives of Gynecology and Obstetrics, 2022, 306 : 1697 - 1701
  • [24] Influence of Lymph Node Status and Treatment Strategy on Overall Survival in Advanced Cervical Cancer
    Knobloch, Stella
    Papathemelis, Thomas
    Gerken, Michael
    Scharl, Anton
    Anapoiski, Michael
    Ignatov, Atanas
    Ortmann, Olaf
    Inwald, Elisabeth C.
    Hetterich, Madeleine
    Scharl, Sophia
    Klinkhammer-Schalke, Monika
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 90 - 90
  • [25] Maintenance bevacizumab following chemotherapy improves survival among patients with advanced and recurrent cervical cancer
    Kuznicki, Michelle
    Kelley, Johanna
    Chau, Danielle
    Bedell, Sabrina
    Yao, Meng
    Yurch, Melissa
    Rose, Peter
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S307 - S308
  • [26] Multiprofessional approach in advanced cervical cancer as a prognostic factor in survival - exenterative surgery and chemotherapy with bevacizumab
    Silva, J. S.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 286 - 287
  • [27] Integration of bevacizumab with chemotherapy doublets for advanced cervical cancer
    Krill, Lauren S.
    Tewari, Krishnansu S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (05) : 675 - 683
  • [28] Development and validation of radiomic signature for predicting overall survival in advanced-stage cervical cancer
    Jha, Ashish Kumar
    Mithun, Sneha
    Sherkhane, Umeshkumar B.
    Jaiswar, Vinay
    Shah, Sneha
    Purandare, Nilendu
    Prabhash, Kumar
    Maheshwari, Amita
    Gupta, Sudeep
    Wee, Leonard
    Rangarajan, V.
    Dekker, Andre
    FRONTIERS IN NUCLEAR MEDICINE, 2023, 3
  • [29] Impact of radiographically bulky nodes on recurrence and overall survival in patients with locally advanced cervical cancer
    Tran, A-Q
    Staley, S. A.
    Sullivan, S. A.
    Kim, K. H.
    Jones, E. L.
    Varia, M.
    Boggess, J. F.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (02) : 284 - 289
  • [30] SURVIVAL ANALYSIS IN ADVANCED CERVICAL CANCER
    Hernandez Ontoria, M.
    Vazquez Sarandeses, A.
    Lopez Gonzalez, G.
    Tejerizo Garcia, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A221 - A222
12345